Kalaris Therapeutics is a clinical-stage company that creates medicines for serious eye diseases. Their main work involves a drug candidate intended to treat vision loss and leaking blood vessels in the back of the eye. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
